相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival
Deep Hathi et al.
SCIENTIFIC REPORTS (2022)
Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages
Julio C. Valencia et al.
CANCER RESEARCH (2021)
Macrophage peroxiredoxin 5 deficiency promotes lung cancer progression via ROS-dependent M2-like polarization
Jung Bae Seong et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Signaling Pathway Mediating Myeloma Cell Growth and Survival
Teru Hideshima et al.
CANCERS (2021)
The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
Almudena Garcia-Ortiz et al.
CANCERS (2021)
Tumor-associated macrophages modulate angiogenesis and tumor growth in a xenograft mouse model of multiple myeloma
Miaomiao Sun et al.
LEUKEMIA RESEARCH (2021)
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics
Stephan M. Tirier et al.
NATURE COMMUNICATIONS (2021)
The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib
Pawel Robak et al.
CANCERS (2021)
Inflammatory Mediators and Gut Microbial Toxins Drive Colon Tumorigenesis by IL-23 Dependent Mechanism
Janani Panneerselvam et al.
CANCERS (2021)
Single-Cell Transcriptomic Analysis Revealed a Critical Role of SPP1/CD44-Mediated Crosstalk Between Macrophages and Cancer Cells in Glioma
Cong He et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma
Shigeki Ito et al.
CANCERS (2021)
Epigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia
Ramin Radpour et al.
FRONTIERS IN ONCOLOGY (2021)
The E50K optineurin mutation impacts autophagy-mediated degradation of TDP-43 and leads to RGC apoptosis in vivo and in vitro
Shiqi Zhang et al.
CELL DEATH DISCOVERY (2021)
CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome
Epameinondas Koumpis et al.
PATHOLOGY RESEARCH AND PRACTICE (2021)
Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFα
Ilseyar Akhmetzyanova et al.
BLOOD ADVANCES (2021)
ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment
Giada Bianchi et al.
BLOOD CANCER DISCOVERY (2021)
Adhesion molecule immunophenotype of bone marrow multiple myeloma plasma cells impacts the presence of malignant circulating plasma cells in peripheral blood
Indre Klimiene et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)
Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination
Ilseyar Akhmetzyanova et al.
LEUKEMIA (2020)
Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone Sites
Xiaoxuan Xu et al.
CANCER RESEARCH (2020)
PD-L1 expression in bone marrow plasma cells as a biomarker to predict multiple myeloma prognosis: developing a nomogram-based prognostic model
Byung-Hyun Lee et al.
SCIENTIFIC REPORTS (2020)
Multiple myeloma current treatment algorithms
S. Vincent Rajkumar et al.
BLOOD CANCER JOURNAL (2020)
Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages
Mei Song et al.
NATURE COMMUNICATIONS (2020)
Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies
Christie P. M. Verkleij et al.
CANCERS (2020)
Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells
Stefan Forster et al.
FRONTIERS IN ONCOLOGY (2020)
Phase 1b trial of pembrolizumab monotherapy for relapsed/ refractory multiple myeloma: KEYNOTE-013
Vincent Ribrag et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
Extracellular Vesicles Enhance Multiple Myeloma Metastatic Dissemination
Michela Colombo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
Maria-Victoria Mateos et al.
LANCET HAEMATOLOGY (2019)
The role of CXCR4 in multiple myeloma: Cells' journey from bone marrow to beyond
Tomalika Rahmat Ullah
JOURNAL OF BONE ONCOLOGY (2019)
High numbers of CD163+tumor-associated macrophages correlate with poor prognosis in multiple myeloma patients receiving bortezomib-based regimens
Hua Wang et al.
JOURNAL OF CANCER (2019)
Increased exhausted CD8+ T cells with programmed death-1, T-cell immunoglobulin and mucin-domain-containing-3 phenotype in patients with multiple myeloma
Jiaxiong Tan et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation
Satoshi Takagi et al.
CLINICAL CANCER RESEARCH (2018)
Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior
Shyam K. Bandari et al.
MATRIX BIOLOGY (2018)
Mechanisms coupling thrombin to metastasis and tumorigenesis
Allison S. Remiker et al.
THROMBOSIS RESEARCH (2018)
Single-cell analysis of tumors: Creating new value for molecular biomarker discovery of cancer stem cells and tumor-infiltrating immune cells
Ramin Radpour et al.
WORLD JOURNAL OF STEM CELLS (2018)
An early history of T cell-mediated cytotoxicity
Pierre Golstein et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Adipose, Bone, and Myeloma: Contributions from the Microenvironment
Michelle M. McDonald et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation
Nathan De Beule et al.
JOURNAL OF PATHOLOGY (2017)
Multiple myeloma
Shaji K. Kumar et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy
Ramin Radpour
WORLD JOURNAL OF STEM CELLS (2017)
Exosomes from metastatic cancer cells transfer amoeboid phenotype to non-metastatic cells and increase endothelial permeability: their emerging role in tumor heterogeneity
Odessa Schillaci et al.
SCIENTIFIC REPORTS (2017)
HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1
Kate Vandyke et al.
CANCER RESEARCH (2017)
In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins
M. Martinez-Moreno et al.
LEUKEMIA (2016)
Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma
Jesus Delgado-Calle et al.
CANCER RESEARCH (2016)
New Developments in Diagnosis, Prognosis, and Assessment of Response in Multiple Myeloma
Ola Landgren et al.
CLINICAL CANCER RESEARCH (2016)
Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis
Christina Ramsenthaler et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins
O. Jung et al.
ONCOGENESIS (2016)
The PD1:PD-L1/2 Pathway from Discovery to Clinical implementation
Kankana Bardhan et al.
FRONTIERS IN IMMUNOLOGY (2016)
Bone metastasis: the importance of the neighbourhood
Peter I. Croucher et al.
NATURE REVIEWS CANCER (2016)
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing
Patrizia Leone et al.
BLOOD (2015)
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche
Michelle A. Lawson et al.
NATURE COMMUNICATIONS (2015)
CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation
Aldo M. Roccaro et al.
CELL REPORTS (2015)
Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo
Nadine Jetten et al.
ANGIOGENESIS (2014)
Osteoblastic niche supports the growth of quiescent multiple myeloma cells
Zheng Chen et al.
BLOOD (2014)
A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events
Swaminathan P. Iyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Platelets guide the formation of early metastatic niches
Myriam Labelle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells
Yawara Kawano et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression
Aldo M. Roccaro et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib
H. A. F. Stessman et al.
LEUKEMIA (2013)
The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis
Naoya Fujita et al.
JOURNAL OF BIOCHEMISTRY (2012)
Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
D. Kim et al.
LEUKEMIA (2012)
Bone Marrow-Derived Mesenchymal Stromal Cells are Attracted by Multiple Myeloma Cell-Produced Chemokine CCL25 and Favor Myeloma Cell Growth in Vitro and In Vivo
Song Xu et al.
STEM CELLS (2012)
Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
Myriam Labelle et al.
CANCER CELL (2011)
Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach
Joan Blade et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients
M. Varettoni et al.
ANNALS OF ONCOLOGY (2010)
Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells
Thomas L. Andersen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
The impact of extramedullary disease at presentation on the outcome of myeloma
Ping Wu et al.
LEUKEMIA & LYMPHOMA (2009)
Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome?
E. Katodritou et al.
LEUKEMIA RESEARCH (2009)
Unusual myeloma relapse after thalidomide therapy: The dark side of the moon?
Enrico Balleari et al.
LEUKEMIA RESEARCH (2009)
Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome
M. C. Minnema et al.
BONE MARROW TRANSPLANTATION (2008)
Extravasation and homing mechanisms in multiple myeloma
Isabelle Vande Broek et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies
Constantine S. Mitsiades et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Recent advances in the treatment of multiple myeloma
Hiroshi Yasui et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2006)
BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACl-Fc treatment in patients with multiple myeloma
M. Abe et al.
LEUKEMIA (2006)
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma
GS Nowakowski et al.
BLOOD (2005)
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation
N Giuliani et al.
BLOOD (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Myeloma of the central nervous system: Strong association with unfavorable chromosomal abnormalities and other high-risk disease features
ABT Fassas et al.
LEUKEMIA & LYMPHOMA (2004)
Clinical course of patients with relapsed multiple myeloma
SK Kumar et al.
MAYO CLINIC PROCEEDINGS (2004)
Dual effects of macrophage inflammatory protein-1α on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease
BO Oyajobi et al.
BLOOD (2003)
Immunocytochemistry reveals RANKL expression of myeloma cells
O Sezer et al.
BLOOD (2002)
Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma
N Sahara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells
G Taraboletti et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells
M Van Driel et al.
LEUKEMIA (2002)
Chemokine stromal cell-derived factor-1α modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1
F Sanz-Rodríguez et al.
BLOOD (2001)
分享论文
